Evergreen Capital Management’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$257K Buy
11,026
+277
+3% +$5.97K 0.01% 1233
2025
Q4
$215K Sell
10,749
-257
-2% -$5.02K ﹤0.01% 1265
2025
Q3
$201K Sell
11,006
-147
-1% -$2.87K ﹤0.01% 1232
2025
Q2
$224K Sell
11,153
-1,025
-8% -$19.7K 0.01% 970
2025
Q1
$221K Sell
12,178
-595
-5% -$10.7K 0.01% 936
2024
Q4
$222K Buy
12,773
+19
+0.1% +$365 0.01% 925
2024
Q3
$246K Buy
12,754
+433
+4% +$7.98K 0.01% 818
2024
Q2
$202K Buy
12,321
+1,209
+11% +$18.8K 0.01% 868
2024
Q1
$169K Hold
11,112
0.01% 814
2023
Q4
$178K Buy
11,112
+192
+2% +$2.69K 0.01% 785
2023
Q3
$142K Sell
10,920
-449
-4% -$5.83K 0.01% 739
2023
Q2
$145K Buy
+11,369
New +$142K 0.01% 761

Other funds holding INVA

Evergreen Capital Management's INVA Position: Q1 2026 in Review

Evergreen Capital Management increased its Innoviva (INVA) stake by 2.6% in Q1 2026, buying an estimated $5.97K and bringing the position to 11,026 shares worth $257K. The position accounts for 0.01% of the portfolio, ranked #1233.

Evergreen Capital Management first reported a position in INVA in Q2 2023 and has held it in 12 quarters since. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.

  • Evergreen Capital Management held 11,026 shares of Innoviva worth $257K as of Q1 2026.
  • Evergreen Capital Management bought 277 Innoviva shares in Q1 2026, an estimated $5.97K.
  • Innoviva made up 0.01% of Evergreen Capital Management's portfolio in Q1 2026, its #1233 holding.
  • Evergreen Capital Management first reported a position in Innoviva in Q2 2023 and has held it in 12 quarters since.
  • 286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.

Based on Evergreen Capital Management's 13F filing for Q1 2026, filed 14 May 2026.